Vera Tocci

发表

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes

A. Brunetti, D. Foti, E. Chiefari, 2021, Journal of clinical medicine.

Plasma or Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL): Which Is Better at Detecting Chronic Kidney Damage in Type 2 Diabetes?

A. Salatino, A. Brunetti, D. Foti, 2022, Endocrines.

A Partial Phenotype of adFNDI Related to the Signal Peptide c.55G>A Variant of the AVP Gene

A. Brunetti, D. Foti, E. Chiefari, 2021, Endocrines.

The Initial ATA Risk Classification, but Not the AJCC/TNM Stage, Predicts the Persistence or Relapse of Differentiated Thyroid Cancer in Long-Term Surveillance

A. Salatino, A. Brunetti, D. Foti, 2022, Endocrines.

Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options.

A. Brunetti, D. Foti, E. Chiefari, 2021, Current opinion in pharmacology.

Maternal Preconception Body Mass Index Overtakes Age as a Risk Factor for Gestational Diabetes Mellitus

A. Salatino, A. Brunetti, D. Foti, 2023, Journal of clinical medicine.

Prothymosin-Alpha, a Novel and Sensitive Biomarker of the Inflammatory and Insulin-Resistant Statuses of Obese Individuals: A Pilot Study Involving Humans

A. Salatino, A. Brunetti, D. Foti, 2023, Endocrines.

Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question

A. Salatino, A. Brunetti, D. Foti, 2023, Pharmaceuticals.